1. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022; 183: 109119.
2. Pang X, Xue W, Feng X, Tian X, Teng Y, Ding X, et al. Experimental studies on islets isolation, purification and function in rats. Int J Clin Exp Med. 2015; 8(11): 20932-20938.
3. Mazzi S, Ravasio R, Forlani G, Veronese G, Fabbri A, Marchesini G. Estimating the risk of severe hypoglycemic event related to glucose-lowering treatment among Italian patients with diabetes: the HYPOTHESIS database. Clinicoecon Outcomes Res. 2017; 9: 711-720.
4. Baharvand H, Jafary H, Massumi M, Ashtiani SK. Generation of insulin-secreting cells from human embryonic stem cells. Dev Growth Differ. 2006; 48(5): 323-332.
5. Khosravi-Maharlooei M, Hajizadeh-Saffar E, Tahamtani Y, Basiri M, Montazeri L, Khalooghi K, et al. Therapy of endocrine disease: islet transplantation for type 1 diabetes: so close and yet so far away. Eur J Endocrinol. 2015; 173(5): R165-R183.
6. Saberzadeh-Ardestani B, Karamzadeh R, Basiri M, Hajizadeh- Saffar E, Farhadi A, Shapiro AMJ, et al. Type 1 diabetes mellitus: cellular and molecular pathophysiology at a glance. Cell J. 2018; 20(3): 294-301.
7. Tavakoli A, Liong S. Pancreatic transplant in diabetes. Adv Exp Med Biol. 2012; 771: 420-437.
8. Zongyi Y, Funian Z, Hao L, Ying C, Jialin Z, Baifeng L. A rapid, efficient, and economic device and method for the isolation and purification of mouse islet cells. PLoS One. 2017; 12(2): e0171618.
9. Bevacqua RJ, Dai X, Lam JY, Gu X, Friedlander MSH, Tellez K, et al. CRISPR-based genome editing in primary human pancreatic islet cells. Nat Commun. 2021; 12(1): 2397.
10. Li Z, Sun H, Zhang J, Zhang H, Meng F, Cui Z. Development of in vitro 3D TissueFlex(R) islet model for diabetic drug efficacy testing. PLoS One. 2013; 8(8): e72612.
11. McCall MD, Maciver AH, Pawlick R, Edgar R, Shapiro AM. Histopaque provides optimal mouse islet purification kinetics: comparison study with Ficoll, iodixanol and dextran. Islets. 2011; 3(4): 144-149.
12. Barre-Sinoussi F, Montagutelli X. Animal models are essential to biological research: issues and perspectives. Future Sci OA. 2015; 1(4): FSO63.
13. Kottaisamy CPD, Raj DS, Prasanth Kumar V, Sankaran U. Experimental animal models for diabetes and its related complications-a review. Lab Anim Res. 2021; 37(1): 23.
14. Carter JD, Dula SB, Corbin KL, Wu R, Nunemaker CS. A practical guide to rodent islet isolation and assessment. Biol Proced Online. 2009; 11: 3-31.
15. NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee; NIH CIT Consortium. Purified human pancreatic islet: qualitative and quantitative assessment of islets using dithizone (DTZ): standard operating procedure of the NIH clinical islet transplantation consortium. CellR4 Repair Replace Regen Reprogram. 2015; 3(1): e1369.
16. NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee; NIH CIT Consortium. Purified human pancreatic islet - viability estimation of islet using fluorescent dyes (FDA/PI): standard operating procedure of the NIH clinical islet transplantation consortium. CellR4 Repair Replace Regen Reprogram. 2015; 3(1): e1378.
17. NIH CIT Consortium Chemistry Manufacturing Controls Monitoring Committee; NIH CIT Consortium. Functional assessment of purified human pancreatic islets: glucose stimulated insulin release by ELISA: a standard operating procedure of the NIH clinical islet transplantation consortium. CellR4 Repair Replace Regen Reprogram. 2014; 2(2): e900.
18. Izadi Z, Hajizadeh-Saffar E, Hadjati J, Habibi-Anbouhi M, Ghanian MH, Sadeghi-Abandansari H, et al. Tolerance induction by surface immobilization of Jagged-1 for immunoprotection of pancreatic islets. Biomaterials. 2018; 182: 191-201.
19. Cantarelli E, Citro A, Marzorati S, Melzi R, Scavini M, Piemonti L. Murine animal models for preclinical islet transplantation: No model fits all (research purposes). Islets. 2013; 5(2): 79-86.
20. Saliba Y, Bakhos JJ, Itani T, Fares N. An optimized protocol for purification of functional islets of Langerhans. Lab Invest. 2017; 97(1): 70-83.
21. de Groot M, de Haan BJ, Keizer PP, Schuurs TA, van Schilfgaarde R, Leuvenink HG. Rat islet isolation yield and function are donor strain dependent. Lab Anim. 2004; 38(2): 200-206.
22. Farney AC, Sutherland DE, Opara EC. Evolution of islet transplantation for the last 30 years. Pancreas. 2016; 45(1): 8-20.
23. Moskalewski S. Isolation and culture of the islets of langerhans of the guinea pig. Gen Comp Endocrinol. 1965; 5: 342-353.
24. Chhabra P, Sutherland D, Brayman KL. Overcoming barriers in clinical islet transplantation: current limitations and future prospects. Curr Probl Surg. 2014; 51(2): 49-86.
25. Strandell E, Sandler S. In vitro response to interleukin-1 beta and streptozotocin in pancreatic islets isolated from male and female nonobese diabetic mice. J Endocrinol. 1997; 153(1): 81-86.
26. de Haan BJ, Faas MM, Spijker H, van Willigen JW, de Haan A, de Vos P. Factors influencing isolation of functional pancreatic rat islets. Pancreas. 2004; 29(1): e15-22.
27. Al-Adra DP, Gill RS, Imes S, O’Gorman D, Kin T, Axford SJ, et al. Single-donor islet transplantation and long-term insulin independence in select patients with type 1 diabetes mellitus. Transplantation. 2014; 98(9): 1007-1012.
28. Matsumoto S, Noguchi H, Naziruddin B, Onaca N, Jackson A, Nobuyo H, et al. Improvement of pancreatic islet cell isolation for transplantation. Proc (Bayl Univ Med Cent). 2007; 20(4): 357-362.
29. Tze WJ, Tai J. Effect of body weight on islet isolation in rats. Transplantation. 1982; 34(1): 68.
30. Saliba Y, Fares N. Isolation, purification, and culture of mouse pancreatic islets of langerhans. Methods Mol Biol. 2019; 1940: 255-265.
31. O’Dowd JF, Stocker CJ. Isolation and purification of rodent pancreatic islets of langerhans. Methods Mol Biol. 2020; 2076: 179-184.
32. Loganathan G, Graham ML, Radosevich DM, Soltani SM, Tiwari M, Anazawa T, et al. Factors affecting transplant outcomes in diabetic nude mice receiving human, porcine, and nonhuman primate islets: analysis of 335 transplantations. Transplantation. 2013; 95(12): 1439-1447.
33. Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, et al. Clinical outcomes and insulin secretion after islet transplantation with the Edmonton protocol. Diabetes. 2001; 50(4): 710-719.
34. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000; 343(4): 230-238.
35. Song S, Yeung R, Park J, Posselt AM, Desai TA, Tang Q, et al. Glucose-stimulated insulin response of silicon nanopore-immunoprotected islets under convective transport. ACS Biomater Sci Eng. 2017; 3(6): 1051-1061.
36. Hajizadeh-Saffar E, Tahamtani Y, Aghdami N, Azadmanesh K, Habibi-Anbouhi M, Heremans Y, et al. Inducible VEGF expression by human embryonic stem cell-derived mesenchymal stromal cells reduces the minimal islet mass required to reverse diabetes. Sci Rep. 2015; 5: 9322.
37. Montazeri L, Hojjati-Emami S, Bonakdar S, Tahamtani Y, Hajizadeh- Saffar E, Noori-Keshtkar M, et al. Improvement of islet engraft by enhanced angiogenesis and microparticle-mediated oxygenation. Biomaterials. 2016; 89: 157-16.